Biotech Business - April 20, 2021
Lipum becomes listed on Nasdaq First North
On Thursday, April 22, shares in Lipum will be traded on the Nasdaq First North Growth Market for the very first time. The company will ring Nasdaq’s opening bell, which has been specially transported to Umeå, to mark the occasion. Begin clinical trials in the spring of 2022 Lipum has developed a biological drug candidate […]
In a new job - February 5, 2021
Lipum appoints new Chief Financial Officer
Lipum has appointed Marina Norberg as their new Chief Financial Officer (CFO). Marina Norberg has extensive experience as an approved auditor at PwC and as authorized accounting consultant within Aspia AB, the management team of which she belonged. She will report to CEO Einar Pontén and be part of Lipum’s management team. “I am very pleased […]
In a new job - January 1, 2020
Anders Fasth joins Lipum’s scientific board
The scientific advisory board of Lipum has been strengthened with Anders Fasth, senior professor of pediatric immunology at the University of Gothenburg and a senior consultant at Queen Silvia Children’s Hospital in Gothenburg, Sweden. “I started treating children with rheumatism several decades ago. We today have effective medicines to choose from, but still many children […]
